Advertisement

Topics

Glioblastoma, anaplastic astrocytoma treatment receives orphan status

06:00 EDT 7 Sep 2017 | SmartBrief

Deciphera Pharmaceuticals' DCC-2618 candidate to treat glioblastoma multiforme and anaplastic astrocytoma has received a new  -More

Original Article: Glioblastoma, anaplastic astrocytoma treatment receives orphan status

NEXT ARTICLE

More From BioPortfolio on "Glioblastoma, anaplastic astrocytoma treatment receives orphan status"

Quick Search
Advertisement
 

Relevant Topic

Brain Cancer
According to the American Brain Tumor Association, just over 24,000 patients will be diagnosed with a primary malignant brain tumour during 2012 in the US alone. Some 80% of primary malignant brain tumours are gliomas, a broad term which includes all tum...